Literature DB >> 9288378

Tracheostomy in a neuro-intensive care setting: indications and timing.

W Y Koh1, T W Lew, N M Chin, M F Wong.   

Abstract

A retrospective review was made of 49 survivors who were mechanically ventilated for more than 48 hours in the neurosurgical ICU. Thirty-two patients (Gp I) were successfully extubated, 9 patients (Gp II) underwent tracheostomy after one or more failed extubations, and 8 patients (Gp III) underwent elective tracheostomy. Glasgow Coma Scale (GCS) scores at extubation were 11.3 +/- 2.8 (mean (SD) for Gp I vs 7.8 +/- 2.7 for Gp II (P = n.s.) and at elective tracheostomy (Gp III) was 5.4 +/- 2.3. Incidence of ventilator-associated pneumonia were 35% in Gp I vs 100% of patients in Gp II and III (P < 0.05). Reasons for reintubation in 7 of 9 patients (Gp II) were upper airway obstruction and tenacious tracheal secretions while 14 of 17 patients were weaned off the ventilator within 48 hours of tracheostomy. The length of stay in ICU was 16.8 +/- 7.1 days in Gp II vs 11.7 +/- 2.9 days in Gp III (P < 0.05). In our study, elective tracheostomy for selected patients with poor GCS scores and nosocomial pneumonia has resulted in shortened ICU length of stay and rapid weaning from ventilatory support.

Entities:  

Mesh:

Year:  1997        PMID: 9288378     DOI: 10.1177/0310057X9702500407

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  21 in total

1.  Experience with two different techniques of percutaneous dilational tracheostomy in 54 neurosurgical patients.

Authors:  Wolfgang Börm; Markus Gleixner
Journal:  Neurosurg Rev       Date:  2003-02-01       Impact factor: 3.042

2.  Percutaneous dilational tracheostomy in neurosurgical patients.

Authors:  Samuel R Browd; Joel D MacDonald
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

3.  How does care differ for neurological patients admitted to a neurocritical care unit versus a general ICU?

Authors:  Pedro Kurtz; Vincent Fitts; Zeynep Sumer; Hillary Jalon; Joseph Cooke; Vladimir Kvetan; Stephan A Mayer
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

4.  Impact of tracheostomy timing on outcome after severe head injury.

Authors:  Elias B Rizk; Akshal S Patel; Christina M Stetter; Vernon M Chinchilli; Kevin M Cockroft
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

5.  The TRACH score: clinical and radiological predictors of tracheostomy in supratentorial spontaneous intracerebral hemorrhage.

Authors:  Viktor Szeder; Santiago Ortega-Gutierrez; Wendy Ziai; Michel T Torbey
Journal:  Neurocrit Care       Date:  2010-08       Impact factor: 3.210

6.  Repeat percutaneous tracheostomy in the neurocritically ill patient.

Authors:  Murat Yilmaz; Levent Dosemeci; Melike Cengiz; Suat Sanli; Ognjen Gajic; Atilla Ramazanoglu
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

7.  Inpatient Complications Predict Tracheostomy Better than Admission Variables After Traumatic Brain Injury.

Authors:  Ryne Jenkins; Nicholas A Morris; Bryce Haac; Richard Van Besien; Deborah M Stein; Wan-Tsu Chang; Gary Schwartzbauer; Gunjan Parikh; Neeraj Badjatia
Journal:  Neurocrit Care       Date:  2019-04       Impact factor: 3.210

8.  Risk factors associated with mortality after traumatic cervical spinal cord injury.

Authors:  Takayuki Higashi; Hideto Eguchi; Yusuke Wakayama; Masakatsu Sumi; Tomoyuki Saito
Journal:  OTA Int       Date:  2018-05-16

9.  Resource utilization in the management of traumatic brain injury patients in a critical care unit: An audit from a rural set-up of a developing country.

Authors:  Amit Agrawal; Nitish Baisakhiya; Anand Kakani; Manda Nagrale
Journal:  Int J Crit Illn Inj Sci       Date:  2011-01

10.  Neurological Critical Care Services' Influence Following Large Hemispheric Infarction and Their Impact on Resource Utilization.

Authors:  Syed Omar Shah; Yu Kan Au; Fred Rincon; Matthew Vibbert
Journal:  J Crit Care Med (Targu Mures)       Date:  2018-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.